Intrinsiqq
Decoy Therapeutics Inc. logo

Decoy Therapeutics Inc. Insider Trading

DCOY

Compare
Last 12 months

Insiders sold $17 and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Nov 2025.

Net open-market
−$17
0 buys · 1 sale
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 1
executives and directors
Last open-market buy
Nov 2025
Nov 20, 2025

Get an email when DCOY's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Dec 30, 2025No plan
    Arnold C Hanish
    Director · sold 27 at avg $0.64
    $17
    0.5% of stake
  • Nov 20, 2025
    Arnold C Hanish
    Director · bought 5,000 at $0.75
    4K
    18519% of stake
  • Nov 20, 2025
    Mark J Rosenblum
    Exec VP Finance, CFO · bought 20,000 at $0.80
    16K
    11299% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DCOY, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with DCOY

CompareIntrinsic value
SCPXScorpius Holdings Inc.
$0.00+0.00%10
CPMDCannapharmaRx Inc.
$0.00+0.00%24
SGMTSagimet Biosciences Inc.
$9.12-5.20%10
ORMPOramed Pharmaceuticals Inc.
$3.57-3.25%35
DNTHDianthus Therapeutics Inc.
$84.55-0.33%10
CYCNCyclerion Therapeutics Inc.
$35.45+6.55%40
PLRXPliant Therapeutics Inc.
$0.60-4.02%10
MCRBSeres Therapeutics, Inc.
$1.24-6.77%0

Held by ETFs

DCOY is in 1 US ETF. The largest of them, with DCOY's weight in each:

Spot a number that looks wrong? Check it in DCOY's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing DCOY

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.